by John A. Jenkins | Mar 26, 2026 | FDA, FOIA
FOIAengine: How FOIA Requests Pointed to Problems at Boston Scientific Months before Boston Scientific expanded its urgent warning this month about the risk of sudden death from its Accolade pacemakers, something quieter was happening inside the U.S. Food and Drug...
by John A. Jenkins | Mar 11, 2026 | DOJ, FOIA, Politics, SEC
FOIAengine: How a Grassroots Movement Saw New Evidence of a Conspiracy In December, a retired California Highway Patrol officer named Wilma Stone filed an unusual Freedom of Information Act request with the Securities and Exchange Commission. Stone asked the agency...
by John A. Jenkins | Feb 11, 2026 | FOIA, News Media
FOIAengine: Hundreds of Requests Probing How FDA Weighs Risk and Responds to Warnings A new tranche of just-released Freedom of Information Act requests from news organizations shows how reporters are using the act as an investigative tool to reconstruct internal...
by John A. Jenkins | Feb 4, 2026 | FDA, FOIA, Litigation, Pharmaceuticals, Stock Market
FOIAengine: Media Requests Were Warnings, Months Before Bad News Hit In the early days of the Covid pandemic, there was big money on the line as pharmaceutical companies scrambled to produce vaccines. The world needed a miracle. The companies that could deliver it...
by John A. Jenkins | Jan 14, 2026 | FDA, FOIA, News Media, Pharmaceuticals
FOIAengine: Warning Letters and Inspection Reports in the Spotlight Freedom of Information Act requests filed with the Food and Drug Administration by hedge funds last month revealed big financial players closely eyeing warning letters, enforcement documents, and...
